Home > Annual Financials > UNICHEM LABORATORIES

UNICHEM LABORATORIES Financial Statement Analysis
[BOM: 506690|NSE : UNICHEMLAB]

The Revenues of UNICHEM LABORATORIES have increased by 5.76% YoY .
The Earnings Per Share (EPS) of UNICHEM LABORATORIES has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

UNICHEM LABORATORIES Last 5 Annual Financial Results
[BOM: 506690|NSE : UNICHEMLAB]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹1,343 Cr₹1,270 Cr₹1,235 Cr₹1,104 Cr₹1,180 Cr
Expenses ₹1,389 Cr₹1,197 Cr₹1,144 Cr₹1,155 Cr₹1,264 Cr
Operating Profit (Excl OI) ₹-46 Cr₹73 Cr₹91 Cr₹-51 Cr₹-83 Cr
Other Income ₹39 Cr₹48 Cr₹50 Cr₹91 Cr₹98 Cr
Interest ₹17 Cr₹6.11 Cr₹5.12 Cr₹7.85 Cr₹7.52 Cr
Depreciation ₹113 Cr₹91 Cr₹84 Cr₹82 Cr₹67 Cr
Profit Before Tax ₹-176 Cr₹22 Cr₹51 Cr₹-48 Cr₹-60 Cr
Profit After Tax ₹-202 Cr₹33 Cr₹34 Cr₹-60 Cr₹-26 Cr
Consolidated Net Profit ₹-202 Cr₹33 Cr₹34 Cr₹-60 Cr₹-24 Cr
Earnings Per Share (Rs)₹-10.01₹-28.72₹4.70₹4.88₹-8.55
PAT Margin (%)-4.13-15.062.602.78-5.45
ROE(%)-2.95-8.041.281.35-2.34
ROCE(%)-1.47-5.601.002.11-1.46
Total Debt/Equity(x)0.090.120.130.040.07

Key Financials

Market Cap : ₹ 4,194.8 Cr
Revenue (TTM) : ₹ 2,028.9 Cr
Net Profit(TTM) : ₹ 150.6 Cr
EPS (TTM) : ₹ 21.4
P/E (TTM) : 27.9

Industry Peers & Returns1W1M1Y
UNICHEM LABORATORIES -0.5% 0.2% 9.8%
SUN PHARMACEUTICAL INDUSTRIES -0.2% -0.5% 10.7%
DIVIS LABORATORIES 4% 4.8% 50.5%
CIPLA 0.4% 3.1% 1.6%
TORRENT PHARMACEUTICALS 5.9% 9.1% 23%
DR REDDYS LABORATORIES -4.8% 2.2% 2.9%
MANKIND PHARMA -0.9% -5.2% 8.7%
ZYDUS LIFESCIENCES 2.7% 7.8% -6.5%
LUPIN 1.4% 0.1% 22.3%


UNICHEM LABORATORIES Revenues
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

5.76 %

5 Yr CAGR

3.29 %

Years Revenues % Change
Mar2024 ₹1,343 Cr
5.76
Mar2023 ₹1,270 Cr
2.81
Mar2022 ₹1,235 Cr
11.91
Mar2021 ₹1,104 Cr
-6.47
Mar2020 ₹1,180 Cr -


UNICHEM LABORATORIES Operating Profit
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2024 ₹-46 Cr
Negative
Mar2023 ₹73 Cr
-20.10
Mar2022 ₹91 Cr
Positive
Mar2021 ₹-51 Cr
Negative
Mar2020 ₹-83 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2024 -3.39%
Negative
Mar2023 5.73%
-22.36
Mar2022 7.38%
Positive
Mar2021 -4.6%
Negative
Mar2020 -7.08% -

UNICHEM LABORATORIES Profit After Tax
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2024 ₹-202 Cr
Negative
Mar2023 ₹33 Cr
-3.68
Mar2022 ₹34 Cr
Positive
Mar2021 ₹-60 Cr
Negative
Mar2020 ₹-24 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2024 -4.13 %
Negative
Mar2023 -15.06 %
Negative
Mar2022 2.6 %
-6.47
Mar2021 2.78 %
Positive
Mar2020 -5.45 % -

UNICHEM LABORATORIES Earnings Per Share (EPS)
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2024 ₹-10
Negative
Mar2023 ₹-29
Negative
Mar2022 ₹4.70
-3.69
Mar2021 ₹4.88
Positive
Mar2020 ₹-8.55 -

UNICHEM LABORATORIES Return on Capital Employed (ROCE)
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2024 -1.47%
Negative
Mar2023 -5.6%
Negative
Mar2022 1%
-52.61
Mar2021 2.11%
Positive
Mar2020 -1.46% -

UNICHEM LABORATORIES Share Price vs Sensex

Current Share Price : ₹595.9
Current MarketCap: ₹ 4,194.8 Cr
Updated EOD on :Jul 01,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
UNICHEM LABORATORIES

-0.5%

0.2%

9.8%

SENSEX

2%

2.8%

6.4%

UNICHEM LABORATORIES related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE SMALLCAP 2.9% 4.2% 4.7%
BSE HEALTHCARE 2.6% 3.8% 20.6%
No NSE index found

You may also like the below Video Courses


FAQ about UNICHEM LABORATORIES Financials


How the annual revenues of UNICHEM LABORATORIES have changed ?

The Revenues of UNICHEM LABORATORIES have increased by 5.76% YoY .

How the Earnings per Share (EPS) of UNICHEM LABORATORIES have changed?

The Earnings Per Share (EPS) of UNICHEM LABORATORIES has decreased by Negative YoY .